Light Therapy for Circadian Rhythm Disorders in Adolescents
(ALT Trial)
Trial Summary
What is the purpose of this trial?
Chronic circadian misalignment and sleep restriction peak during late adolescence, and are associated with morning daytime sleepiness, poor academic performance, conduct problems, depressed mood, suicidal ideation, substance use, insulin resistance, and obesity. Bright light exposure from light boxes can shift rhythms earlier (phase advance) to facilitate earlier sleep onset and reduce morning circadian misalignment and the associated risks. To phase advance circadian rhythms, the investigators' PRCs showed that the ideal time to begin light exposure was slightly before wake-up time and light should be avoided around bedtime because this is when light produces maximum phase delay shifts. An unexpected finding from these results, however, was a second advancing region in the afternoon (\~6 to 9 h after habitual wake-up time) suggesting that afternoon light may have more circadian phase advancing ability than traditionally thought. The overall goal of this mechanistic study is to follow-up on the unexpected PRC findings and test whether individually-timed afternoon light alone and in combination with morning bright light can shift circadian rhythms earlier in older adolescents. Four groups will be compared in a randomized parallel group design: afternoon bright light, morning bright light, morning + afternoon bright light, and a dim room light control. Adolescents will complete a 2-week protocol. After a baseline week with a stable sleep schedule, adolescents will live in the laboratory for 7 days. Sleep/dark and the time of bright light exposure will gradually shift earlier. Bright light (\~5000 lux) will be timed individually based on his/her stable baseline sleep schedule. The first 3-h morning bright light exposure will begin 1 h before wake on the first morning. The first 3-h afternoon bright light exposure will begin 5 h after wake. The morning + afternoon exposures will begin at the same times, but each exposure will be 1.5 h so that a total of 3 h of bright light per day will be given to each group except the dim light control group. Phase shifts of the circadian clocks marked by the dim light melatonin onset (DLMO) is the main outcome. Investigators hypothesize that afternoon bright light will work synergistically with morning bright light to produce larger shifts than morning or afternoon bright light alone. These data could challenge the current understanding of how to use bright light to shift circadian rhythms earlier.
Will I have to stop taking my current medications?
The trial protocol does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment for circadian rhythm disorders in adolescents?
Research shows that bright light therapy can help shift the body's internal clock in adolescents, making it easier for them to adjust their sleep schedules. Studies have found that bright light exposure can successfully treat circadian rhythm sleep disorders in adolescents, helping them align their sleep patterns with daily life demands.12345
Is light therapy safe for adolescents with circadian rhythm disorders?
How does the treatment 'Light Therapy for Circadian Rhythm Disorders in Adolescents' differ from other treatments?
This treatment is unique because it uses bright light therapy to shift the body's internal clock, helping adolescents align their sleep patterns with their daily schedules. Unlike other treatments that may focus on medication or behavioral changes, this approach directly targets the circadian system by timing light exposure to optimize sleep and wake times.124910
Eligibility Criteria
This trial is for late adolescents aged 18-20 who live in or near Chicago, IL. It's designed to help those struggling with sleep issues and circadian rhythm misalignment that can lead to mood problems, poor academic performance, and health risks.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Sleep Schedule
Participants maintain a stable sleep schedule at home to ensure they are not sleep deprived before lab sessions
Laboratory Phase
Participants live in the laboratory for 7 days with scheduled bright light exposure to shift circadian rhythms
Follow-up
Participants are monitored for changes in circadian phase using DLMO assessments
Treatment Details
Interventions
- Baseline Sleep Satiation and Phase Stabilization
- Gradually Shifted Sleep
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor